Listen Top Shows Blog

BREAKWATER: Charting New Waters in Advanced BRAFmt CRC with Dr. Rachel Goodwin

BREAKWATER: Charting New Waters in Advanced BRAFmt CRC with Dr. Rachel Goodwin

Update: 2025-11-24

Share

Description

As we now access Encorafenib + Cetuximab + Folfox via a Pfizer sponsored PSP for the he first line treatment Braf V600e mutated, RAS wt, dMMR/MSS metastatic Colorectal cancer, Dr. Rachel Goodwin takes us through the regimen, its practical use and efficacy and toxicity management.

Comments

In Channel

BREAKWATER: Charting New Waters in Advanced BRAFmt CRC with Dr. Rachel Goodwin

BREAKWATER: Charting New Waters in Advanced BRAFmt CRC with Dr. Rachel Goodwin

2025-11-2434:54

Inavolisib in Endocrine Resistant PIK3CA Mutated HR+, HER2- Breast Cancer with Dr. Kasia Jerzak

Inavolisib in Endocrine Resistant PIK3CA Mutated HR+, HER2- Breast Cancer with Dr. Kasia Jerzak

2025-10-0732:58

TDXD a new DESTINY for HER2+ Gastro/GEJ adeno in 2nd line with Dr. Brezden-Masley

TDXD a new DESTINY for HER2+ Gastro/GEJ adeno in 2nd line with Dr. Brezden-Masley

2025-09-1636:13

Check or Checkmate Ipi/Nivo in HCC with Dr. Hatim Karachiwala

Check or Checkmate Ipi/Nivo in HCC with Dr. Hatim Karachiwala

2025-09-1132:53

IPI/NIVO for mCRC with Dr. Sharlene Gill

IPI/NIVO for mCRC with Dr. Sharlene Gill

2025-08-2133:23

The CHALLENGE to Move and Survive: Exercise After Adjuvant Colon Cancer Treatment with Dr. Christopher Booth

The CHALLENGE to Move and Survive: Exercise After Adjuvant Colon Cancer Treatment with Dr. Christopher Booth

2025-08-1130:11

Amivantamab + Lazertinib in 1st line Advanced EGFR + NSCLC - Mariposa

Amivantamab + Lazertinib in 1st line Advanced EGFR + NSCLC - Mariposa

2025-06-0250:12

Claudin 18.2 - a SPOTLIGHT on Zolbetuximab - Part 2 of 2

Claudin 18.2 - a SPOTLIGHT on Zolbetuximab - Part 2 of 2

2025-05-1639:42

Claudin 18.2 - a GLOW-ing biomarker in Gastric Cancer - Part 1 of 2

Claudin 18.2 - a GLOW-ing biomarker in Gastric Cancer - Part 1 of 2

2025-05-0649:41

Take 2 Aspirin and call me in the morning - Adjuvant therapy for Colorectal Cancer

Take 2 Aspirin and call me in the morning - Adjuvant therapy for Colorectal Cancer

2025-03-2735:18

Resectable NSCLC: How to Choose the Right Treatment

Resectable NSCLC: How to Choose the Right Treatment

2025-03-0345:35

2L Treatment of EGFR-Positive NSCLC

2L Treatment of EGFR-Positive NSCLC

2025-02-1838:40

Belzutifan - A Spark of Light for Clear Cell Renal Cell Carcinoma

Belzutifan - A Spark of Light for Clear Cell Renal Cell Carcinoma

2025-01-3141:49

00:00

00:00

x

BREAKWATER: Charting New Waters in Advanced BRAFmt CRC with Dr. Rachel Goodwin

BREAKWATER: Charting New Waters in Advanced BRAFmt CRC with Dr. Rachel Goodwin

N/A